Novartis Sample Email
2
STOP NOVARTIS – Keep generic medicines available to the millions that depend on them. Thanks for your support! Email Novartis CEO Joe Jimenez at [email protected] and Carrie Scott at [email protected] Subject title: Novartis, Drop Your Case in India! Dear Mr. Jimenez, I am concerned about the court case Novartis is pursuing in India and the implications it has for access to life- saving medicines for people in developing countries. Although Novartis has previously responded to concerns raised by non-governmental organisations such as Medecins Sans Frontieres that "this case will in no way impact access to medicines to poor countries," the truth remains that if the Supreme Court decides in your favour, India will be required to change the way it grants patents. The knock-on effect of changes to Indian patent law will have repercussions reaching beyond Indian borders, to developing countries where people rely on Indian-produced generics. Most worrying is that medicine prices will rise and better adapted medicines, such as fixed-dosed combinations and child-friendly formulations of existing drugs, will not be accessible to the people who need them most. The number of lives impacted by these changes will outstrip those reached through drug donations and access programmes by Novartis and others. Millions currently on treatment may see their lifeline dry up. Mr. Jimenez, drop your case against the pharmacy of the developing world and send a message that Novartis believes that the value of human lives outweighs those of company profits. Sincerely,
-
Upload
friends-of-medecins-sans-frontieres-uk-and-ireland -
Category
Documents
-
view
216 -
download
1
description
Help us tell Novartis ENOUGH is ENOUGH by emailing Novartis CEO Joe Jimenez
Transcript of Novartis Sample Email
STOP NOVARTIS – Keep generic medicines available to the millions that depend on them. Thanks for your support!
Email Novartis CEO Joe Jimenez at [email protected] and Carrie Scott at [email protected]
Subject title: Novartis, Drop Your Case in India!
Dear Mr. Jimenez,
I am concerned about the court case Novartis is pursuing in India and the implications it has for access to life-saving medicines for people in developing countries.
Although Novartis has previously responded to concerns raised by non-governmental organisations such as Medecins Sans Frontieres that "this case will in no way impact access to medicines to poor countries," the truth remains that if the Supreme Court decides in your favour, India will be required to change the way it grants patents.
The knock-on effect of changes to Indian patent law will have repercussions reaching beyond Indian borders, to developing countries where people rely on Indian-produced generics. Most worrying is that medicine prices will rise and better adapted medicines, such as fixed-dosed combinations and child-friendly formulations of existing drugs, will not be accessible to the people who need them most.
The number of lives impacted by these changes will outstrip those reached through drug donations and access programmes by Novartis and others. Millions currently on treatment may see their lifeline dry up.
Mr. Jimenez, drop your case against the pharmacy of the developing world and send a message that Novartis believes that the value of human lives outweighs those of company profits.
Sincerely,
SIGN YOUR NAME HERE
![SAMPLE ONLY [email protected]](https://static.fdocuments.in/doc/165x107/61fb5aa82e268c58cd5d2d9e/sample-only-emailprotected.jpg)
